IRTC | iRhythm Technologies, Inc.

Index- P/E- EPS (ttm)-3.48 Insider Own0.70% Shs Outstand30.30M Perf Week-3.07%
Market Cap3.26B Forward P/E- EPS next Y-2.08 Insider Trans-7.42% Shs Float29.65M Perf Month-19.94%
Income-104.70M PEG- EPS next Q-0.78 Inst Own105.03% Short Float / Ratio7.58% / 6.20 Perf Quarter-4.52%
Sales430.00M P/S7.58 EPS this Y-12.40% Inst Trans0.46% Short Interest2.25M Perf Half Y4.12%
Book/sh7.32 P/B13.99 EPS next Y35.80% ROA-24.00% Target Price153.00 Perf Year-31.36%
Cash/sh5.54 P/C18.49 EPS next 5Y- ROE-44.30% 52W Range85.74 - 164.69 Perf YTD9.34%
Dividend- P/FCF- EPS past 5Y-24.20% ROI-41.50% 52W High-37.81% Beta1.39
Dividend %- Quick Ratio2.90 Sales past 5Y32.90% Gross Margin68.70% 52W Low19.45% ATR5.72
Employees1793 Current Ratio3.10 Sales Q/Q20.60% Oper. Margin-24.40% RSI (14)27.52 Volatility5.62% 4.88%
OptionableYes Debt/Eq0.00 EPS Q/Q24.50% Profit Margin-24.30% Rel Volume1.51 Prev Close101.46
ShortableYes LT Debt/Eq0.16 EarningsMay 04 AMC Payout- Avg Volume362.40K Price102.42
Recom1.80 SMA20-13.91% SMA50-18.64% SMA200-13.04% Volume545,452 Change0.95%
Date Action Analyst Rating Change Price Target Change
Feb-07-23Initiated Wells Fargo Overweight $150
Nov-07-22Upgrade Wolfe Research Underperform → Peer Perform
Jun-09-22Downgrade Citigroup Buy → Neutral $180 → $155
Apr-06-22Initiated Wolfe Research Underperform $105
Feb-24-22Upgrade Needham Hold → Buy $135
Feb-24-22Upgrade Needham Hold → Buy
Jan-18-22Upgrade Morgan Stanley Equal-Weight → Overweight $129 → $167
Jan-12-22Upgrade BTIG Research Neutral → Buy $170
Jan-11-22Upgrade Oppenheimer Perform → Outperform $150
Dec-21-21Resumed Canaccord Genuity Buy $125
Jun-06-23 09:00AM
May-27-23 08:28AM
May-24-23 04:05PM
May-22-23 08:30AM
May-11-23 06:09AM
06:05PM Loading…
May-04-23 06:05PM
Apr-20-23 04:05PM
Apr-14-23 06:51PM
Apr-13-23 12:21PM
Apr-12-23 04:30PM
Apr-02-23 02:07PM
Mar-14-23 07:42AM
Mar-06-23 08:30AM
Mar-02-23 08:30AM
08:04AM Loading…
Feb-25-23 08:04AM
Feb-24-23 02:44PM
Feb-23-23 04:05PM
Feb-21-23 06:57AM
Feb-09-23 04:05PM
Jan-09-23 08:30AM
Dec-27-22 04:30PM
Dec-01-22 01:54PM
Nov-14-22 10:43AM
Nov-07-22 04:05PM
Nov-06-22 12:30PM
Nov-04-22 11:47AM
Nov-02-22 05:45PM
05:45PM Loading…
Nov-01-22 05:45PM
Oct-20-22 04:05PM
Sep-21-22 08:30AM
Aug-31-22 08:30AM
Aug-06-22 05:00AM
Aug-05-22 10:27AM
Aug-04-22 07:15PM
Jul-28-22 04:30PM
Jul-25-22 04:15PM
Jul-22-22 04:52PM
Jul-18-22 04:10PM
Jul-08-22 08:30AM
Jun-27-22 07:38AM
Jun-19-22 09:03AM
May-25-22 04:05PM
May-06-22 04:11PM
May-05-22 06:35PM
Apr-28-22 04:05PM
Apr-21-22 04:05PM
Apr-12-22 11:52AM
Apr-03-22 12:35PM
Mar-29-22 04:05PM
Mar-23-22 09:28AM
Mar-14-22 08:30AM
Feb-28-22 12:59PM
Feb-27-22 10:56PM
Feb-23-22 05:25PM
Feb-09-22 04:05PM
Jan-11-22 07:14AM
Jan-10-22 06:29PM
Dec-29-21 04:05PM
Dec-25-21 11:38AM
Dec-11-21 02:43PM
Nov-04-21 08:56PM
Nov-03-21 04:03PM
Nov-02-21 09:37PM
Oct-25-21 02:52PM
Oct-21-21 04:05PM
Oct-12-21 04:05PM
Oct-05-21 04:05PM
Sep-14-21 07:58AM
Sep-13-21 12:58PM
Sep-06-21 01:19PM
Aug-26-21 04:05PM
Aug-05-21 05:55PM
Jul-29-21 04:05PM
Jul-22-21 04:05PM
Jul-21-21 05:17AM
Jul-14-21 06:00AM
Jul-08-21 09:00AM
Jul-06-21 03:52PM
Jun-02-21 08:41AM
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shrishrimal SumiEVP, Chief Risk OfficerJun 02Sale111.451,109123,59818,707Jun 05 04:07 PM
Wilson Daniel G.EVP, Corp Dev Inv RelMar 29Sale125.004,000500,00035,337Mar 30 07:32 PM
Day Mark J.Chief Technology OfficerMar 03Sale117.232,116248,05954,815Mar 07 02:06 PM
Devine DouglasChief Operating OfficerMar 03Sale117.231,473172,68029,566Mar 07 02:02 PM
Wilson Daniel G.EVP, Strategy Corp Dev Inv RelMar 03Sale117.231,422166,70139,337Mar 07 02:04 PM
Murphy Patrick MichaelCLO & EVP RA/QA MrktAcs & GovMar 03Sale117.2357166,93832,437Mar 07 02:09 PM
Devine DouglasChief Operating OfficerFeb 28Sale117.843,518414,56331,039Mar 01 06:26 PM
Day Mark J.Chief Technology OfficerFeb 28Sale117.841,913225,43156,931Mar 01 06:09 PM
Wilson Daniel G.EVP, Strategy Corp Dev Inv RelFeb 28Sale117.841,726203,39540,759Mar 01 06:30 PM
Murphy Patrick MichaelCLO & EVP RA/QA MrktAcs & GovDec 02Sale106.781,704181,95323,726Dec 06 04:37 PM
Wilson Daniel G.EVP, Strategy Corp Dev Inv RelDec 01Sale109.141,000109,14033,562Dec 05 04:21 PM
Blackford Quentin S.President and CEONov 02Sale122.4012,6991,554,39889,280Nov 04 02:20 PM
Devine DouglasChief Operating OfficerSep 29Sale125.002,000250,00027,702Sep 30 09:31 PM
Wilson Daniel G.EVP, Strategy Corp Dev Inv RelSep 26Sale122.573,000367,71634,562Sep 28 11:05 AM
Bairey Merz Cathleen NoelDirectorSep 12Sale159.779014,3794,887Sep 14 02:16 PM
Devine DouglasChief Operating Officer & CFOJul 07Sale114.2210,1091,154,65029,702Jul 11 12:15 PM
Wilson Daniel G.EVP, Strategy Corp Dev Inv RelJul 05Sale108.931,428155,55337,562Jul 07 02:01 PM
Devine DouglasChief Operating Officer & CFOJul 05Sale108.901,239134,92539,811Jul 07 01:59 PM
Bairey Merz Cathleen NoelDirectorJun 14Sale111.7650055,8804,977Jun 16 12:50 PM